This Confidential Biotech Client is a biopharmaceutical company that researches and develops transformative therapeutics to treat high prevalence retinal diseases globally. This new 66,500sf corporate headquarters for research labs and offices in Palo Alto’s choice Stanford Research Park includes two floors of lab and office space, cafeteria, and site modifications. This project provides the client with the necessary space to continue towards their goal of developing a next-generation platform for retinal medicines.